We are live on ! Find out more
BA

Bard Associates Portfolio holdings

AUM $398M
1-Year Est. Return 54.32%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+54.32%
3 Year Est. Return
+200.06%
5 Year Est. Return
+225.83%
10 Year Est. Return
+1,331.15%
AUM
$174M
AUM Growth
+$4.06M
Cap. Flow
+$7.47M
Cap. Flow %
4.3%
Top 10 Hldgs %
21.89%
Holding
169
New
9
Increased
30
Reduced
81
Closed
4

Sector Composition

Rank Sector Weight
1 Real Estate 15.92%
2 Industrials 13.73%
3 Technology 12.63%
4 Materials 10.79%
5 Healthcare 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TIO
126
DELISTED
Tingo Group, Inc. Common Stock
TIO
$304K 0.18%
152,090
-500
-0.3% -$995
EYPT icon
127
EyePoint Inc
EYPT
$1.02B
$300K 0.17%
11,181
+4,000
+56% +$126K
ICLR icon
128
Icon
ICLR
$12.7B
$293K 0.17%
3,900
-3,900
-50% -$273K
JOF
129
Japan Smaller Capitalization Fund
JOF
$322M
$289K 0.17%
29,922
-400
-1% -$3.75K
HROW icon
130
Harrow
HROW
$1.44B
$260K 0.15%
+65,500
New +$318K
GPX
131
DELISTED
GP Strategies Corp.
GPX
$253K 0.15%
9,250
TOVX icon
132
Theriva Biologics
TOVX
$9.68M
$248K 0.14%
12
AGF
133
DELISTED
DB Agriculture Long ETN due April 1, 2038
AGF
$244K 0.14%
23,170
-40
-0.2% -$434
GLAD icon
134
Gladstone Capital
GLAD
$421M
$216K 0.12%
14,525
GDX icon
135
VanEck Gold Miners ETF
GDX
$22.7B
$208K 0.12%
10,395
-70
-0.7% -$1.2K
GLD icon
136
SPDR Gold Trust
GLD
$131B
$208K 0.12%
+1,766
New +$200K
CGO
137
Calamos Global Total Return Fund
CGO
$125M
$205K 0.12%
18,525
-225
-1% -$2.35K
CGNT
138
DELISTED
Cogentix Medical, Inc.
CGNT
$202K 0.12%
183,882
-3,123
-2% -$3.51K
ANIX icon
139
Anixa Biosciences
ANIX
$117M
$183K 0.11%
60,800
FMO
140
DELISTED
Fiduciary/Claymore Energy Infrastructure Fund
FMO
$168K 0.1%
3,071
SNAK
141
DELISTED
Inventure Foods, Inc.
SNAK
$152K 0.09%
26,950
+10,750
+66% +$62K
RLOG
142
DELISTED
Rand Logistics, Inc.
RLOG
$144K 0.08%
151,705
-8,200
-5% -$8.63K
AUY
143
DELISTED
Yamana Gold, Inc.
AUY
$141K 0.08%
46,515
-3,064
-6% -$7.49K
LMFAW
144
DELISTED
LM Funding America, Inc. Warrant
LMFAW
0
OHAI
145
DELISTED
OHA Investment Corporation
OHAI
$131K 0.08%
38,615
-2,500
-6% -$8.33K
LAYN
146
DELISTED
Layne Christensen Co
LAYN
$125K 0.07%
17,355
-400
-2% -$2.33K
QCLS
147
Q/C Technologies Inc
QCLS
$21M
0
MDLY
148
DELISTED
Medley Management Inc
MDLY
$96K 0.06%
1,750
MBAI
149
Check-Cap
MBAI
$8.12M
$93K 0.05%
140
GTE icon
150
Gran Tierra Energy
GTE
$264M
$88K 0.05%
3,550
-65
-2% -$1.51K

Similar funds

Bard Associates's Q1 2016 Portfolio in Review

As of Q1 2016, Bard Associates held 169 positions worth $174M, up 2.4% from $170M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Bard Associates deployed $7.47M of net new capital in Q1 2016, opening 9 new positions and adding to 30 existing holdings. Its largest new stake was Hooper Holmes Inc: 679,036 shares worth $1.42M.

By sector, the portfolio is most concentrated in Real Estate at 16% of assets, down from 16% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Tyler Technologies, an estimated $1.43M trimmed.

  • Bard Associates's largest Q1 2016 buy was Hooper Holmes Inc: 679,036 shares worth $1.42M.
  • Bard Associates added most to USA Compression Partners in Q1 2016, an estimated $2.2M increase.
  • Bard Associates's biggest Q1 2016 reduction was Tyler Technologies, cutting an estimated $1.43M.
  • Bard Associates fully exited Teva Pharmaceuticals in Q1 2016, selling an estimated $217K.
  • Bard Associates's ten largest holdings make up 22% of its $174M portfolio in Q1 2016.
  • Bard Associates opened 9 new positions and closed 4 in Q1 2016.
  • Bard Associates's portfolio value rose 2.4% quarter-over-quarter to $174M.

Based on Bard Associates's 13F filing for Q1 2016, filed 12 May 2016.